TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α

The development of proliferative podocytopathies has been linked to ligation of TNFR2 expressed on the renal parenchyma; however, the TNFR2 positive cells within the kidney responsible for podocyte injury are unknown. We detected de novo expression of TNFR2 on podocytes prior to hyperplastic injury...

Full description

Bibliographic Details
Main Authors: Bruggeman, Leslie A., Drawz, Paul E., Kahoud, Nicole, Lin, Ke, Barisoni, Laura, Nelson, Peter J.
Format: Online
Language:English
Published: 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075956/
id pubmed-3075956
recordtype oai_dc
spelling pubmed-30759562011-09-01 TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α Bruggeman, Leslie A. Drawz, Paul E. Kahoud, Nicole Lin, Ke Barisoni, Laura Nelson, Peter J. Article The development of proliferative podocytopathies has been linked to ligation of TNFR2 expressed on the renal parenchyma; however, the TNFR2 positive cells within the kidney responsible for podocyte injury are unknown. We detected de novo expression of TNFR2 on podocytes prior to hyperplastic injury in crescentic glomerulonephritis of mice with nephrotoxic nephritis, and in collapsing glomerulopathy of Tg26HIV/nl mice, kd/kd mice, and humans. We further found that serum levels of soluble TNF-α and TNFR2 correlated significantly with renal injury in Tg26HIV/nl mice. Thus, we asked whether ligand binding of TNFR2 on podocytes ex vivo precipitates the characteristic proliferative and pro-inflammatory diseased podocyte phenotypes. Soluble TNF-α activated NF-κB and dose-dependently induced podocyte proliferation, marked by expression of the podocyte G1 cyclin and NF-κB target gene, cyclin D1. Microarray gene and chemokine protein expression profiling showed a marked pro-inflammatory NF-κB signature, and activated podocytes secreting CCL2 and CCL5 induced macrophage migration in transwell assays. Neutralization of TNFR2 on podocytes with blocking antibodies abrogated NF-κB activation and the induction of cyclin D1 by TNF-α, and identified TNFR2 as the primary receptor that induced IκBα degradation, the initiating event in NF-κB activation. These results suggest that TNFR2 expressed on podocytes and its canonical NF-κB signaling may directly interpose the compound pathogenic responses by podocytes to TNF-α, absent other TNFR2 positive renal cell-types in proliferative podocytopathies. 2011-01-10 2011-03 /pmc/articles/PMC3075956/ /pubmed/21221075 http://dx.doi.org/10.1038/labinvest.2010.199 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Bruggeman, Leslie A.
Drawz, Paul E.
Kahoud, Nicole
Lin, Ke
Barisoni, Laura
Nelson, Peter J.
spellingShingle Bruggeman, Leslie A.
Drawz, Paul E.
Kahoud, Nicole
Lin, Ke
Barisoni, Laura
Nelson, Peter J.
TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α
author_facet Bruggeman, Leslie A.
Drawz, Paul E.
Kahoud, Nicole
Lin, Ke
Barisoni, Laura
Nelson, Peter J.
author_sort Bruggeman, Leslie A.
title TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α
title_short TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α
title_full TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α
title_fullStr TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α
title_full_unstemmed TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α
title_sort tnfr2 interposes the proliferative and nf-κb-mediated inflammatory response by podocytes to tnf-α
description The development of proliferative podocytopathies has been linked to ligation of TNFR2 expressed on the renal parenchyma; however, the TNFR2 positive cells within the kidney responsible for podocyte injury are unknown. We detected de novo expression of TNFR2 on podocytes prior to hyperplastic injury in crescentic glomerulonephritis of mice with nephrotoxic nephritis, and in collapsing glomerulopathy of Tg26HIV/nl mice, kd/kd mice, and humans. We further found that serum levels of soluble TNF-α and TNFR2 correlated significantly with renal injury in Tg26HIV/nl mice. Thus, we asked whether ligand binding of TNFR2 on podocytes ex vivo precipitates the characteristic proliferative and pro-inflammatory diseased podocyte phenotypes. Soluble TNF-α activated NF-κB and dose-dependently induced podocyte proliferation, marked by expression of the podocyte G1 cyclin and NF-κB target gene, cyclin D1. Microarray gene and chemokine protein expression profiling showed a marked pro-inflammatory NF-κB signature, and activated podocytes secreting CCL2 and CCL5 induced macrophage migration in transwell assays. Neutralization of TNFR2 on podocytes with blocking antibodies abrogated NF-κB activation and the induction of cyclin D1 by TNF-α, and identified TNFR2 as the primary receptor that induced IκBα degradation, the initiating event in NF-κB activation. These results suggest that TNFR2 expressed on podocytes and its canonical NF-κB signaling may directly interpose the compound pathogenic responses by podocytes to TNF-α, absent other TNFR2 positive renal cell-types in proliferative podocytopathies.
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075956/
_version_ 1611449267881246720